Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.6200
-0.0453 (-6.81%)
At close: Jun 26, 2026, 4:00 PM EDT
0.6900
+0.0700 (11.29%)
After-hours: Jun 26, 2026, 7:43 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $17.95 million as of June 26, 2026. Its market cap has decreased by -58.37% in one year.
Market Cap
17.95M
Enterprise Value
86.48M
1-Year Change
-58.37%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $17.95M, a decrease of -94.90%. That is a compound annual growth rate of -35.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 17.95M | -43.23% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 21.84M |
| VYNE Therapeutics | 21.74M |
| Polyrizon | 21.38M |
| Allarity Therapeutics | 20.21M |
| Cellectar Biosciences | 19.74M |
| Palatin Technologies | 19.66M |
| Lipocine | 19.62M |
| NewcelX | 19.11M |